News & Blog

News & Blog

  • Reset
News | Jul 7 2025

Press Release: Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia

Industry News
Blog | Jul 7 2025

Meet the Community: Megan Ploch

Community
News | Jul 3 2025

June/July 2025 – Advocacy Newsletter

Advocacy
News | Jun 30 2025

Press Release: Muscular Dystrophy Association and Friedreich’s Ataxia Research Alliance Announce New Collaborative Grant to Study Cardiac Fibrosis in Friedreich’s Ataxia

FARA News
Blog | Jun 30 2025

Meet the Community: Kailey Newcity

Community
Blog | Jun 23 2025

2025 Cure FA Soirée Recap

Events
News | Jun 23 2025

Press Release: Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program

Industry News
News | Jun 18 2025

Press Release and Community Statement: Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia

Industry News
Blog | Jun 16 2025

Meet the Community: Mark Kuchmas

Community
Blog | Jun 9 2025

Meet the Community: Luciana Grasiele Nogueira

Community
News | Jun 5 2025

Webinar Recording: Biogen May 2025 Update

FARA News | Industry News
News | Jun 5 2025

Webinar Recording: Lexeo Therapeutics May 2025 Update

FARA News | Industry News